Cargando…
Candidate composite biomarker to inform drug treatments for diabetic kidney disease
INTRODUCTION: Current guidelines recommend renin angiotensin system inhibitors (RASi) as key components of treatment of diabetic kidney disease (DKD). Additional options include sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide 1 receptor agonists (GLP1a), and mineralocortico...
Autores principales: | Jones, Roger D., Abebe, Seyum, Distefano, Veronica, Mayer, Gert, Poli, Irene, Silvestri, Claudio, Slanzi, Debora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646536/ https://www.ncbi.nlm.nih.gov/pubmed/38020124 http://dx.doi.org/10.3389/fmed.2023.1271407 |
Ejemplares similares
-
Designing Lead Optimisation of MMP-12 Inhibitors
por: Borrotti, Matteo, et al.
Publicado: (2014) -
Do Natural Proteins Differ from Random Sequences Polypeptides? Natural vs. Random Proteins Classification Using an Evolutionary Neural Network
por: De Lucrezia, Davide, et al.
Publicado: (2012) -
Artificial life and evolutionary computation: 12th Italian workshop, WIVACE 2017, Venice, Italy, September 19-21, 2017, revised selected papers
por: Pelillo, Marcello, et al.
Publicado: (2018) -
Massive non-natural proteins structure prediction using grid technologies
por: Minervini, Giovanni, et al.
Publicado: (2009) -
Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)